Abstract: A garage door opener system includes a garage door opener having one or more sensors configured to monitor the status of a garage door as it moves between first and second positions. The garage door opener system may detect one or more anomalies in a profile generated from information from the one or more sensors and alert a user to the presence of those anomalies. The garage door opener system may allow a user to find and contact a service provider to address the one or more anomalies.

Abstract: An electrical connection assembly of a medical device includes a plurality of electrical contact blocks and a sealing member, which are held within a cavity of a base of the assembly. The sealing member includes a plurality of openings, at least one interior surface surrounding a bore and at least one void. Each electrical contact block extends into a corresponding opening of the sealing member, and a conductive sidewall of each block defines a portion of a perimeter of an area for receiving a lead connector, while the bore of the sealing member forms another portion of the perimeter of the area. The at least one void provides a compressible space in a bulk volume of the sealing member. When the lead is inserted within the area, and a cap is engaged with the base, the at least one interior surface of the sealing member is compressed about the lead.

Abstract: An electrical connection assembly of a medical device includes a plurality of electrical contact blocks and a sealing member, which are held within a cavity of a base of the assembly. The sealing member includes a plurality of openings, at least one interior surface surrounding a bore and at least one void. Each electrical contact block extends into a corresponding opening of the sealing member, and a conductive sidewall of each block defines a portion of a perimeter of an area for receiving a lead connector, while the bore of the sealing member forms another portion of the perimeter of the area. The at least one void provides a compressible space in a bulk volume of the sealing member. When the lead is inserted within the area, and a cap is engaged with the base, the at least one interior surface of the sealing member is compressed about the lead.

Abstract: An electrical connection assembly of a medical device includes at least one conductive sidewall mounted in a fixed position to a module base; the sidewall may be electrically coupled to a feedthrough wire. The assembly further includes at least one resilient member to apply a spring force against a connector element of a lead connector when the connector element is positioned adjacent to the conductive sidewall. The spring force of the resilient member causes electrical coupling between the connector element and the conductive sidewall.

Abstract: An electrical connection assembly of a medical device includes at least one conductive sidewall mounted in a fixed position to a module base; the sidewall may be electrically coupled to a feedthrough wire. The assembly further includes at least one resilient member to apply a spring force against a connector element of a lead connector when the connector element is positioned adjacent to the conductive sidewall. The spring force of the resilient member causes electrical coupling between the connector element and the conductive sidewall.

Abstract: An electrical connection assembly of a medical device includes at least one conductive sidewall mounted in a fixed position to a module base; the sidewall may be electrically coupled to a feedthrough wire. The assembly further includes at least one resilient member to apply a spring force against a connector element of a lead connector when the connector element is positioned adjacent to the conductive sidewall. The spring force of the resilient member causes electrical coupling between the connector element and the conductive sidewall.

Abstract: An electrical connection assembly of a medical device includes at least one conductive sidewall mounted in a fixed position to a module base; the sidewall may be electrically coupled to a feedthrough wire. The assembly further includes at least one resilient member to apply a spring force against a connector element of a lead connector when the connector element is positioned adjacent to the conductive sidewall. The spring force of the resilient member causes electrical coupling between the connector element and the conductive sidewall.

Abstract: Systems and methods for coordinated delivery of a therapeutic agent and low (less than about 20 Hz) and high (greater than about 50 Hz) frequency stimulation therapy are described. The systems include a control unit for coordinating therapy delivery between an infusion device and a pulse generator, such that a therapeutic agent is administered at a predetermined time relative to application of either low frequency or high frequency stimulation. For example, the control unit may instruct the infusion device to deliver therapeutic agent at a predetermined time prior to delivery of low frequency stimulation. Systems that include more than one infusion device or an infusion pump capable of delivering more than one therapeutic agent are also described.

Abstract: A miniature drug delivery pump utilizes a shape memory Ni-Ti alloy. A flow restrictor is provided and the pump is refillable.

Abstract: Enhanced therapies for treating pain are described. The therapies include subcutaneous stimulation of tissue in proximity to a source of pain at low frequencies (less than about 20 Hz) and high frequencies (greater than about 50 Hz). The therapies further include administering a pain treating agent at a predetermined time relative to application of the high or low frequency stimulation. Delivery of the pain treating agent via an implantable infusion system is described. Coordination of output of an infusion device and a pulse generator to provide coordinated therapy is also discussed.

Abstract: Enhanced therapies for treating pain are described. The therapies include subcutaneous stimulation of tissue in proximity to a source of pain at low frequencies (less than about 20 Hz) and high frequencies (greater than about 50 Hz). The subcutaneous stimulation may be applied in proximity to a structure in the back, such as discs, facet joints, nerve roots or ganglions, sympathetic chain, ligaments, muscles, and the like. Subcutaneous stimulation at high and low frequencies applied in combination with epidural stimulation is also described.

Abstract: Extravascular implantable medical devices are described. The devices include a polymeric layer comprising a polymeric matrix and pores. Therapeutic agent is loaded in the matrix, in the pores, or in the matrix and the pores. The devices include a structural surface layer. Additional therapeutic agent may be loaded in or on the surface layer. The devices may also include one or more intermediate layer, into or onto which additional therapeutic agent may be loaded.

Abstract: Methods for manufacturing medical devices comprising a polymeric material capable of releasing a therapeutic agent upon contact with bodily tissue or fluid are described. The method includes generating polymeric material having a matrix into or onto which a therapeutic agent is disposed and having pores. The method further includes disposing additional therapeutic agent into the pores of the polymeric material.

Abstract: Medical devices configured to be implanted in two or more tissues simultaneously are discussed. A therapeutic agent is disposed on, in, or about at least a portion of an external surface of a medical device configured to be placed in one tissue, but not on, in or about a surface configured to be placed in another tissue. The therapeutic agent may be disposed on or in a polymeric material, which is disposed on or about at least a portion of an external surface of first portion the medical device. Such targeted placement of polymeric material may allow for the therapeutic agent to be eluted in an appropriate tissue and may allow for decreased undesired effects.

Abstract: Implantable medical devices (IMDS) having anti-infective properties are described. Anti-infective agents are disposed in, on, or about at least a portion of a surface of the medical device. The anti-infective agents are disposed in or on a vehicle, which may be in the form of a coating layer or covering. The vehicle may be biodegradable so that, over time, the anti-infective agent is removed from a tissue location into which the device is implanted, reducing the likelihood that microorganisms resistant to the anti-infective agent will develop. IMDs having an anti-infective agent and an anti-activity agent disposed therein, thereabout, or thereon are also described. The anti-activity agent interferes with the activity of the anti-infective agent, may be released from a surface at the IMD at a time when activity of the anti-infective agent is no longer desired, and may reduce the likelihood that microorganisms resistant to the anti-infective agent will develop.

Abstract: An anti-infective covering for an implantable medical device is described. The covering may be a polymeric boot that comprises an anti-infective agent in an amount effective to prevent an infection when implanted in a pocket of a patient. The boot is configured to snuggly engage at least a portion of the implantable medical device. The boot may contain a side hole that allows a housing of the implantable medical device to serve as a return electrode. The boot may be placed about the implantable medical device to render the device anti-infective.

Abstract: A system, method and apparatus relating to a therapeutic substance delivery patch for attachment to a patient such that the patch is in contact with the patient's skin, wherein the patch coordinates its delivery of the therapeutic substance to the patient based on information received relating to the operation of the implanted device. The information received by the patch may be received through telemetry from the implanted device, or alternatively from the patch sensing the action of the implanted device, or alternatively from the patch sensing the patient's physiologic reaction to the action taken by the implanted device.

Abstract: Devices, systems and methods for delivering one or more drugs to one or more internal body locations (such as the cerebrospinal fluid) are disclosed. In various aspects, the systems and methods may involve catheters having infusion sections with permeable membranes and one or more valves that control flow to the infusion sections.

Abstract: Devices, systems and methods for delivering one or more drugs to one or more internal body locations (such as the cerebrospinal fluid) are disclosed. In various aspects, the systems and methods may involve catheters having infusion sections with permeable membranes and one or more valves that control flow to the infusion sections.

Abstract: Devices, systems and methods for delivering one or more drugs to one or more internal body locations (such as the cerebrospinal fluid) are disclosed. In various aspects, the systems and methods may involve catheters having infusion sections with permeable membranes and one or more tracking elements that may be used to place the infusions sections on the catheters in selected locations such as the spinal region.